| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6195011 | American Journal of Ophthalmology | 2015 | 21 Pages |
Abstract
At 6 years, CXL maintains long-term results in halting the progression of corneal ectasia, with significant improvement in CDVA and long-term stability of keratometry. Further clinical studies with longer follow-up and larger series would be necessary to definitely confirm these results.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Muriel Poli, Amélie Lefevre, Céline Auxenfans, Carole Burillon,